Skip to main content
CRVO
NASDAQ Life Sciences

CervoMed Registers 10M Shares for Resale from Recent Private Placement, Potential $21.8M from Warrants

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$3.57
Mkt Cap
$48.289M
52W Low
$2.13
52W High
$13.13
52W Position info
68% above low
Off High info
73% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

CRVO sits 68% above its 52-week low of $2.13 on light trading volume (0.1× avg).

Summary

CervoMed filed an S-3 to register 10.08 million shares for resale by selling stockholders from a recent private placement, representing a significant potential market overhang. The company could receive up to $21.8 million if associated warrants are exercised for cash, which is crucial given its going concern warning.


Key Events · Financing and Capital Events · CRVO

  • Registration of Shares for Resale

    CervoMed registered 10,081,131 shares of common stock for resale by selling stockholders, including shares underlying warrants.

  • Origin from Private Placement

    These shares originate from a private placement that closed on June 11, 2026, which included significant insider participation.

  • Potential Dilution Overhang

    The registered shares represent approximately 74.5% of the company's currently outstanding shares, creating a substantial market overhang.

  • Potential Proceeds from Warrant Exercises

    The company could receive up to $21.8 million if all associated warrants are exercised for cash, which would be used for working capital and general corporate purposes.


Analysis · CRVO · Life Sciences

This S-3 filing enables investors from the June 2026 private placement to sell their shares, creating a substantial overhang on CervoMed's stock, as these shares represent approximately 74.5% of currently outstanding shares. While the company will not receive proceeds from the direct resale, it stands to gain up to $21.8 million if the associated warrants are exercised for cash. This potential capital infusion is vital for CervoMed, which recently reported a going concern warning and has been actively raising funds to extend its cash runway.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRVO was trading at $3.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $48.3M. The 52-week trading range was $2.13 to $13.13. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRVO - Latest Insights

CRVO
Nov 06, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.42
Real-time Price: $1.70 info
Change: +$0.2773 (+20%) info
Market Cap: $25.567M info
CRVO
Oct 29, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.75
Real-time Price: $1.70 info
Change: -$0.0527 (-3%) info
Market Cap: $25.567M info
CRVO
Oct 12, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.02
Real-time Price: $1.70 info
Change: -$1.32 (-44%) info
Market Cap: $25.567M info
CRVO
Sep 28, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.63
Real-time Price: $1.70 info
Change: -$0.9327 (-35%) info
Market Cap: $25.567M info
CRVO
Sep 28, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.64
Real-time Price: $1.70 info
Change: -$0.9377 (-36%) info
Market Cap: $25.567M info